Compare IDN & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDN | BTMD |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.5M | 65.8M |
| IPO Year | 2014 | 2021 |
| Metric | IDN | BTMD |
|---|---|---|
| Price | $2.82 | $1.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $7.33 | $2.83 |
| AVG Volume (30 Days) | ★ 225.4K | 212.2K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 220.00 | ★ 722.22 |
| EPS | ★ 0.06 | N/A |
| Revenue | $4,433,454.00 | ★ $192,219,000.00 |
| Revenue This Year | $12.54 | $2.03 |
| Revenue Next Year | $15.32 | $6.58 |
| P/E Ratio | $125.00 | ★ N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $3.59 | $1.27 |
| 52 Week High | $9.08 | $3.61 |
| Indicator | IDN | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 22.73 | 31.74 |
| Support Level | N/A | $1.35 |
| Resistance Level | $4.49 | $1.69 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 6.22 | 8.33 |
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.